Background:HERC2 encodes an E3 ubiquitin ligase that plays a critical role in brain development. Loss-of-function variants are associated with severe neurodevelopmental phenotypes, including intellectual disability, epilepsy, and various structural anomalies. This report aimed to expand phenotypic spectrum of HERC2-related disorders, including an unusual cardiac manifestation. Case Presentation: The proband, a male infant born to consanguineous parents, presented with myoclonia-like eyelid movements at 50-days old and subsequently developed severe neuromotor regression and choreoathetotic movements. Brain magnetic resonance imaging revealed diffuse cerebral atrophy, corpus callosum thinning, and bilateral pachygyria. He also exhibited distinct dysmorphic features and dilated cardiomyopathy, confirmed by echocardiography. His sibling presented with similar features, including severe developmental delay and dilated cardiomyopathy. Whole-exome sequencing identified a homozygous likely pathogenic c.7645C>T (p.Gln2549Ter) variant in the HERC2 gene. This case report is significant as it describes dilated cardiomyopathy in MRT38, a manifestation not previously associated with HERC2 variants. The unusual cardiac phenotype suggests a potential link between HERC2 dysfunction and mitochondrial impairment, contributing to cardiomyopathy. Conclusion: These patients underscore the importance of recognizing novel clinical features associated with the HERC2 LoF variants, which can guide disease characterization and patient management.

1.
Sánchez-Tena
S
,
Cubillos-Rojas
M
,
Schneider
T
,
Rosa
JL
.
Functional and pathological relevance of HERC family proteins: a decade later
.
Cell Mol Life Sci
.
2016
;
73
(
10
):
1955
68
.
2.
Elpidorou
M
,
Best
S
,
Poulter
JA
,
Hartill
V
,
Hobson
E
,
Sheridan
E
, et al
.
Novel loss-of-function mutation in HERC2 is associated with severe developmental delay and paediatric lethality
.
J Med Genet
.
2021
;
58
(
5
):
334
41
.
3.
Galligan
JT
,
Martinez-Noël
G
,
Arndt
V
,
Hayes
S
,
Chittenden
TW
,
Harper
JW
, et al
.
Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2
.
J Proteome Res
.
2015
;
14
(
2
):
953
66
.
4.
Puffenberger
EG
,
Jinks
RN
,
Wang
H
,
Xin
B
,
Fiorentini
C
,
Sherman
EA
, et al
.
A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder
.
Hum Mutat
.
2012
;
33
(
12
):
1639
46
.
5.
Harlalka
GV
,
Baple
EL
,
Cross
H
,
Kühnle
S
,
Cubillos-Rojas
M
,
Matentzoglu
K
, et al
.
Mutation of HERC2 causes developmental delay with Angelman-like features
.
J Med Genet
.
2013
;
50
(
2
):
65
73
.
7.
Vincent
KM
,
Eaton
A
,
Yassaee
VR
,
Miryounesi
M
,
Hashemi-Gorji
F
,
Rudichuk
L
, et al
.
Delineating the expanding phenotype of HERC2‐related disorders: the impact of biallelic loss of function versus missense variation
.
Clin Genet
.
2021
;
100
(
5
):
637
40
.
8.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
, et al
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
9.
Yavarna
T
,
Al-Dewik
N
,
Al-Mureikhi
M
,
Ali
R
,
Al-Mesaifri
F
,
Mahmoud
L
, et al
.
High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders
.
Hum Genet
.
2015
;
134
(
9
):
967
80
.
10.
Morice-Picard
F
,
Benard
G
,
Rezvani
HR
,
Lasseaux
E
,
Simon
D
,
Moutton
S
, et al
.
Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype
.
Eur J Hum Genet
.
2016
;
25
(
1
):
52
8
.
11.
Abraham
JR
,
Barnard
J
,
Wang
H
,
Noritz
GH
,
Yeganeh
M
,
Buhas
D
, et al
.
Proteomic investigations of human HERC2 mutants: insights into the pathobiology of a neurodevelopmental disorder
.
Biochem Biophys Res Commun
.
2019
;
512
(
2
):
421
7
.
12.
Russell
OM
,
Gorman
GS
,
Lightowlers
RN
,
Turnbull
DM
.
Mitochondrial diseases: hope for the future
.
Cell
.
2020
;
181
(
1
):
168
88
.
13.
Witters
P
,
Saada
A
,
Honzik
T
,
Tesarova
M
,
Kleinle
S
,
Horvath
R
, et al
.
Revisiting mitochondrial diagnostic criteria in the new era of genomics
.
Genet Med
.
2018
;
20
(
4
):
444
51
.
14.
Meyers
DE
,
Basha
HI
,
Koenig
MK
.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management
.
Tex Heart Inst J
.
2013
;
40
(
4
):
385
94
.
15.
Braunwald
E
.
Mitochondrial cardiomyopathy: a fertile field for research
.
Oxford University Press US
;
2023
.
16.
Koenig
MK
.
Presentation and diagnosis of mitochondrial disorders in children
.
Pediatr Neurol
.
2008
;
38
(
5
):
305
13
.
17.
Holmgren
D
,
Wåhlander
H
,
Eriksson
BO
,
Oldfors
A
,
Holme
E
,
Tulinius
M
.
Cardiomyopathy in children with mitochondrial disease: clinical course and cardiological findings
.
Eur Heart J
.
2003
;
24
(
3
):
280
8
.
You do not currently have access to this content.